Understanding Neurofibromatosis (NF): Causes, Symptoms, and Treatments

Understanding Neurofibromatosis (NF): Causes, Symptoms, and Treatments

Julie Scott, DNP
Julie Scott, DNP
Neurofibromatosis (NF) | cancerGO

What is Neurofibromatosis (NF)?

Neurofibromatosis (NF)  is a genetic disorder affecting nerve cell growth and development. It is characterized by the development of benign tumors called neurofibromas on nerve tissue and other symptoms.

There are three types of neurofibromatosis: NF1, NF2, and Schwannomatosis. NF1 is the most common type of neurofibromatosis and is caused by a mutation in the NF1 gene. The condition is inherited in an autosomal dominant manner, meaning that an affected individual has a 50% chance of passing the mutation on to each of their children.

NF2 is caused by a mutation in the NF2 gene. The condition is inherited in an autosomal dominant manner. Schwannomatosis is caused by a mutation in either the SMARCB1 or LZTR1 gene. It is also inherited in an autosomal dominant manner.

Symptoms

Each type of neurofibromatosis can have somewhat different symptoms. Some of these symptoms can include:

  • Skin pigment changes
  • Multiple cafe-au-lait spots on the skin
  • Multiple neurofibromas (tumors that develop along nerves) in multiple areas of the body
  • Bone abnormalities
  • Pain
  • Weakness

The tumors associated with neurofibromatosis are non-cancerous (benign), but some may have an increased cancer risk. Where the neurofibromas develop and how large they become can lead to other symptoms.

Diagnosis

The diagnosis of neurofibromatosis is based on clinical symptoms and evaluation of the tumors. Genetic testing can confirm the diagnosis. Imaging studies such as MRI or CT scans can also be used to evaluate the size and location of tumors.

Treatment

Treatment for neurofibromatosis depends on the type and severity of the symptoms. In some cases, no specific treatment may be needed other than observation.

For others, surgery may be used to remove tumors causing pain or other problems.

In 2020, medication was approved to treat NF1 in children over 2 with certain types of tumors. The medication, Koselugo, works by blocking an enzyme the tumors need to grow.

 

NF can be a mild condition or one that causes severe disability. There is currently no cure, but treatments are available to manage symptoms and help people with NF live full lives. With early diagnosis and treatment, most people with NF have a good prognosis. If you or someone you know has signs or symptoms of NF, make an appointment with your doctor.

Julie Scott, DNP
Julie Scott, DNP
Julie is an oncology certified Oncology Nurse Practitioner with over a decade of medical oncology experience. In addition to her clinical work, she is an accomplished healthcare writer providing oncology content for various publications. She also serves as an adjunct faculty member for a Master's nursing program and a chair for Doctoral nursing students.

Download our
mobile app

Share this post
You may also like
Articles
The Little-known Cancer – Cancer of Unknown Primary (CUP)
November 4, 2022

CUP, also known as Cancer of unknown primary, is Cancer that has metastasized from another body part. The site where it began, also called the primary site, is unknown in this case. Why CUP is a challenging cancer? Cancer of unknown primary is often challenging because it tends to be…

Vino Cherian

administrator

Articles
Amyloidosis
March 1, 2023

What is Amyloidosis? Amyloidosis is a rare condition that occurs when an abnormal protein, called amyloid, builds up in the body's organs and tissues. Over time, this buildup can cause damage and lead to organ failure. Here's an overview of the symptoms, diagnosis, and treatment of amyloidosis. Symptoms The symptoms…

Julie Scott, DNP

author

Articles
Chemotherapy Administration
March 1, 2023

How is Chemotherapy administered? Chemotherapy is a commonly used treatment for cancer that uses medication to kill cancer cells. There are several different ways that Chemotherapy can be administered, and the best method for a patient will depend on the type of cancer they have and where it’s located. Intravenous…

Julie Scott, DNP

author

cancerGO gives you access to a community

Where are people to listen, answer questions, share information, and offer valuable and timely advice